IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function.
Speake C, Habib T, Lambert K, Hundhausen C, Lord S, Dufort MJ, Skinner SO, Hu A, Kinsman M, Jones BE, Maerz MD, Tatum M, Hocking AM, Nepom GT, Greenbaum CJ, Buckner JH.
Speake C, et al. Among authors: hundhausen c.
JCI Insight. 2022 Nov 22;7(22):e159436. doi: 10.1172/jci.insight.159436.
JCI Insight. 2022.
PMID: 36282595
Free PMC article.